Mazdutide
Dual-agonist for metabolic health
Weight Losssubcutaneousany
Overview
Dual GLP-1/glucagon receptor agonist being developed for obesity and NASH. Similar profile to other incretin mimetics with glucagon benefits.
Dosing
- Typical Dosage
- 2.5-6 mg
- Frequency
- Weekly
- Cycle Duration
- Ongoing
- Administration
- subcutaneous
Available Vial Sizes
5mg10mg
In clinical trials. May have benefits for fatty liver disease.
Comprehensive Information
AI-GeneratedGenerating comprehensive analysis...
This may take a moment
Mechanism of Action
Key Benefits
Optimal Timing
Potential Side Effects
Stacking Suggestions
Practical Tips
Could not load AI-generated information
Track Your Mazdutide Protocol
Join UpgradeYourself to track your peptide protocols, log injections with our interactive body map, and receive AI-powered insights tailored to your health goals.
Free forever planNo credit card required100+ peptides tracked